NNVC ▲ +1.4% - NanoViricides, Inc.
$NNVC - As Ebola Spreads to Multiple Countries, the Importance of NV-387 Oral Gummies Treatment Cannot be Understated - Phase II Clinical Trial Advancing Towards the Second Part, Says NanoViricides
27-OCT-2026 09:15 AM ET
Share this post
More filings for $NNVC
NNVC ▼ -0.8% - NanoViricides, Inc.Oct 20, 2026NNVC ▼ -3.8% - NanoViricides, Inc.Oct 13, 2026NNVC ▲ +4.0% - NanoViricides, Inc.Sep 29, 2026NNVC ▼ -2.1% - NanoViricides, Inc.Sep 28, 2026NNVC ▲ +5.2% - NanoViricides, Inc.Sep 23, 2026NNVC ▼ -0.9% - NanoViricides, Inc.Sep 8, 2026
View full $NNVC filing history →💬 Comments
Loading comments…
Leave a comment
